Tuesday, November 1, 2011

Conflicting Results in Clinical Trials: the APC Example

Dan posted last week on activated protein C (Xigris) being withdrawn from the market.  David Rind (Evidence in Medicine blog) has posted his thoughts on what might have been behind the initial positive study in 2001 and subsequent negative studies.  It is worth a read.

David Rind: APC and Conflicting Trials (10/29/2011)

No comments:

Post a Comment

Thanks for submitting your comment to the Controversies blog. To reduce spam, all comments will be reviewed by the blog moderator prior to publishing. However, all legitimate comments will be published, whether they agree with or oppose the content of the post.

OSHA! OSHA! OSHA!

  In many parts of the country, as rates of COVID-19 are declining and vaccination coverage is increasing (albeit with substantial variati...